ALYSSA RODANICHE: Open Payments
NPI 1821609355 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,811 in 83 payments from 21 companies in 2025. Trend: 2023 $1,260 · 2024 $263 · 2025 $1,811
Food & beverage: $1,811
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $409 |
| Axsome Therapeutics, Inc. | 7 | $212 |
| Lilly USA, LLC | 6 | $180 |
| AstraZeneca Pharmaceuticals LP | 9 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $100 |
| Kowa Pharmaceuticals America, Inc. | 6 | $95 |
| Astellas Pharma US Inc | 5 | $92 |
| ABBVIE INC. | 4 | $86 |
| Dexcom, Inc. | 4 | $78 |
| GlaxoSmithKline, LLC. | 3 | $66 |
Products named: MOUNJARO, Rybelsus, Auvelity, Ozempic, FARXIGA, Kerendia, ZORYVE, Wegovy.
Industry payments across TX — which companies pay providers there.
